Efficacy Enhancement of Cefepime with Lemon Leaf-Reduced Silver Nanoparticles against Drug-Resistant Bacteria
Current Microbiology · 2026
DOI: 10.1007/s00284-025-04658-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Asma Irshad und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan. Hauptthemen laut MEDLINE: Silver, Cefepime, Anti-Bacterial Agents, Metal Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Antibiotic-resistant bacterial strains and their massive proliferation of infectious diseases present a critical challenge for treatment with conventional antibiotics i.e. cefepime. To address this, the present investigation explores an eco-friendly approach to enhance cefepime's antibacterial efficacy with silver nanoparticles biologically synthesized using lemon leaf extract as a reducing agent. The concentration, functional groups, structural morphology, elemental analysis and crystalline phase purity, all were confirmed through various characterization techniques i.e. UV-Vis, FT-IR, SEM-EDX, and XRD, respectively. Further, antibacterial analysis was carried out through agar well diffusion, MIC and anti-biofilm assay against Gram-positive strain S. aureus (ATCC 25923) and Gram-negative strain E. coli (ATCC 15597), while biosafety potential was investigated via antioxidant, hemolysis and anti-inflammatory assays. The cefepime-conjugated silver nanoparticles (CEF-Ag NPs) exhibited significantly enhanced antibacterial efficacy compared to cefepime itself, showing inhibition zones of 25 ± 0.5 mm (S. aureus) and 22 ± 0.6 mm (E. coli) at MIC value of 100 ± 0.01 µg/mL. In addition, biofilm inhibition assay demonstrated a substantial reduction in biofilm formation, with optical densities decreasing from 0.55 ± 0.03 at 100 µg/mL to 0.20 ± 0.01 at 1000 µg/mL. Biological safety evaluations showed hemolysis rate of 3.5 ± 0.2% at 200 µg/mL. Regarding DPPH radical scavenging, it was observed with 81 ± 0.03% at 125 µg/mL, and 85 ± 0.04% reduction in inflammation at 125 µg/mL. These findings suggested that CEF-Ag NPs have not only enhanced antimicrobial efficacy but it is also biocompatible, making a promising candidate for combating multidrug-resistant bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan.
- Department of Research and Development, Paktex Industries, 2.5 KM Tatlay Road, Saroya Abad, Kamoke, 52470, Pakistan. uzairsaroya9@gmail.com.
- Department of Life Sciences, School of Sciences, University of Management and Technology, Lahore, Pakistan. uzairsaroya9@gmail.com.
- Organic Biomolecular Research Group, Research Institute, Faculty of Pharmacy and Bioanalysis, University of Los Andes, Mérida, 5101, Venezuela.
- Unité Transformations & Agroressources, ULR7519, Université d'Artois, 1230 rue de l'Université, Béthune, 62408, France.
- Unité Transformations & Agroressources, ULR7519, Université d'Artois, 1230 rue de l'Université, Béthune, 62408, France. patrick.martin@univ-artois.fr.
Zitieren
APA
Irshad, A., Mir, M. A., Ishtiaq, U., Rojas, J., Lequart, V., Martin, P., Mushtaq, Q., & Jawad, R. (2026). Efficacy Enhancement of Cefepime with Lemon Leaf-Reduced Silver Nanoparticles against Drug-Resistant Bacteria. Current Microbiology. https://doi.org/10.1007/s00284-025-04658-4
Vancouver
Irshad A, Mir MA, Ishtiaq U, Rojas J, Lequart V, Martin P, et al. Efficacy Enhancement of Cefepime with Lemon Leaf-Reduced Silver Nanoparticles against Drug-Resistant Bacteria. Current Microbiology. 2026. doi:10.1007/s00284-025-04658-4
BibTeX
@article{Irshad2026,
author = {Irshad, Asma and Mir, Mahrukh Afzal and Ishtiaq, Uzair and Rojas, Janne and Lequart, Vincent and Martin, Patrick and Mushtaq, Qudsia and Jawad, Rabbia},
title = {Efficacy Enhancement of Cefepime with Lemon Leaf-Reduced Silver Nanoparticles against Drug-Resistant Bacteria},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-025-04658-4}
}
EUVIMED